Skip to content
OpenCapital
Get started

Neurocrine Biosciences NBIX EPS (Diluted)

EPS (Diluted) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.31+9.2%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$0.02-81.8%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-$1.23-18.3%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
-$0.52+11.9%
MapLight Therapeutics, Inc. logo
MapLight Therapeutics, Inc. MPLT
-$1.34+95.4%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$0.84+4.5%

Other financials

Income statement

See full
Revenue$814.5M+42.2%
Gross profit$800.7M+42.1%
Operating income$193.4M+719%
Net income$197.9M+2,405%

Balance sheet

See full
Cash & equivalents$274.5M+35.8%
Total debt$463.5M-6.0%
Total equity$3.4B+34.4%
Total assets$4.9B+33.0%

Cash flow

See full
Operating cash flow$145.8M+125%
CapEx$9.1M-15.0%
Free cash flow$136.7M+153%

Valuation

See full
Market cap$17.3B+30.9%
Enterprise value$17.49B+30.2%
P/E25.9×-12.1×
P/S5.6×+0.3×

Profitability

See full
Gross margin98.2%-0.3pp
Operating margin25.4%+4.9pp
Net margin21.6%+8.9pp
FCF margin26.8%+6.4pp

Returns & leverage

See full
Return on equity22.5%+10.1pp
Debt / equity0.1×-0.1×
Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neurocrine Biosciences's EPS (diluted)?
Neurocrine Biosciences (NBIX) reported EPS (diluted) of $1.91 in Q1 2026.
How has Neurocrine Biosciences's EPS (diluted) changed year-over-year?
Neurocrine Biosciences's EPS (diluted) increased by 2287.5% year-over-year, from $0.08 to $1.91.
What is the long-term trend for Neurocrine Biosciences's EPS (diluted)?
Over 4 years (2021 to 2025), Neurocrine Biosciences's EPS (diluted) has grown at a 47.3% compound annual growth rate (CAGR), from $0.99 to $4.66.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.